Vertan Technologies: Pioneering AI-Driven Nanotechnology

February 17, 2025

Last week, at the San Diego VC Outlook event in Del Mar, I had the chance to meet Dr. Gregory Vertelov from Vertan Technologies. I was particularly intrigued by their innovative work at the intersection of nanotechnology and AI-driven solutions.

What is Vertan Technologies?

Vertan Technologies is a nanotechnology holding company that focuses on AI-enhanced therapeutics and consumer products. Their flagship technology, NobleFusion™ nanoparticles, combines gold, silver, and platinum to create bio-active formulations. These can be applied across multiple industries, including medicine, cosmetics, agriculture, and veterinary science. Their AI platform, EurekaAI®, optimizes these formulations, accelerating product development while reducing R&D costs.

Key Areas of Innovation

Vertan’s innovations center around three major applications, with cosmetics being the first target:

  1. Cosmetics: Anti-aging and anti-inflammatory solutions enhanced by noble metals.

  2. Antimicrobial Applications: Targeting antibiotic-resistant bacteria across human, veterinary, and agricultural sectors.

  3. Cancer Treatment: Platinum-based nanoparticles for targeted drug delivery, reducing side effects compared to conventional therapies.

Founded in 2024, Vertan Technologies is led by Dr. Regina Vertelova and Dr. Gregory Vertelov, with support from scientific advisors at UCSD and Princeton. Their vision is to integrate AI and nanotechnology to create transformative, high-performance solutions across industries.

Why Vertan Stands Out

What truly sets Vertan apart is their combination of nanotechnology and AI. The NobleFusion™ nanoparticles, leveraging gold, silver, and platinum, hold the potential to revolutionize cancer treatment, cosmetics, and antimicrobial applications. With EurekaAI®, they are able to optimize formulations, cutting down R&D time and costs. In oncology, for example, their platinum nanoparticles enable targeted drug delivery, improving treatment effectiveness while reducing side effects.

Focus on Cosmetics: Anti-Aging Application

Here’s my internal memo on their cosmetics application:

The Problem:

  • Aging population: By 2030, 1 in 6 people will be over 60, creating a market valued at $88 billion by 2028.

  • Ineffective skincare: 72% of users see no results, and 90% of products lack clinical efficacy.

  • Skin inflammation and oxidative stress: 90% of aging is caused by oxidative stress, with 50 million Americans suffering from chronic skin inflammation.

The Solution: NobleFusion™ Technology

Vertan’s patented NobleFusion™ technology enhances the absorption of active ingredients and provides proven anti-aging and anti-inflammatory benefits. Their formulations, supported by clinical studies, include gold and silver nanoparticles, which offer anti-inflammatory, antioxidant, and UV-protective effects.

  • Global anti-aging skincare market: $50 billion per year, with a $16 billion market in the U.S.

  • Expansion into hair loss ($24B) and anti-acne markets ($10B)

Business Model

  • Product sales

  • IP licensing (e.g., $1M–$10M upfront + 5% royalties)

  • Co-branding and white labeling

Go-to-Market Strategy

  • Partnering with skincare device companies (e.g., MultiFrax)

  • Influencer marketing (Instagram, TikTok, YouTube)

  • E-commerce, direct sales, and distributors

Competitive Edge

Vertan’s integration with MultiFrax—a leader in binary laser skincare devices—gives them a unique positioning in the market. Combined with their patent-protected nanotechnology, clinically proven efficacy, and sustainable materials, they offer a competitive edge at a moderate cost.

Company Structure & Leadership

  • Scientific Advisory Board: Includes leaders from UCSD and Princeton.

Core Business

  • Company Focus: Nanotechnology solutions using AI-driven systems

  • Key Product: NobleFusion™ nanoparticles

  • Core Areas: Medicine, cosmetics, agriculture, and veterinary science

  • AI System: EurekaAI® for optimizing formulations and accelerating development

Core Technologies

  • NobleFusion™ Nanoparticles

    • Multi-metal nanoparticles using gold, silver, and platinum

    • Stable and bioactive formulations

    • Targeted for various applications (cancer, cosmetics, antimicrobials)

  • EurekaAI® System

    • AI-driven platform

    • Optimizes formulations through machine learning and data analysis

    • Reduces R&D costs and accelerates product development

Key Areas of Innovation

1. Advanced Cosmetics and Anti-Aging Solutions

  • Problem: Aging and skin inflammation need effective solutions.

  • Solution: NobleFusion™ nanoparticles for:

    • Enhanced absorption of active ingredients

    • Anti-aging and anti-inflammatory benefits

    • Gold and silver nanoparticles: Known for antimicrobial and anti-inflammatory properties

    • Miramistin: Added antibacterial and antiviral properties

  • Market Expansion: Partnerships with laser cosmetic device companies

2. Antimicrobial Applications

  • Problem: Antibiotic-resistant bacteria are a growing global health issue.

  • Solution: Silver-based NobleFusion™ nanoparticles for:

    • Human Medicine: Treating infections resistant to antibiotics

    • Veterinary Medicine: Effective for treating bacterial infections in animals

    • Agriculture: Reducing reliance on chemical pesticides while enhancing crop yields

  • Advantages: Reduces resistance by disrupting bacterial cell structures

3. Cancer Treatment: Targeted Drug Delivery

  • Problem: Traditional chemotherapy damages healthy cells alongside cancerous ones.

  • Solution: NobleFusion™ platinum nanoparticles for:

    • Targeted delivery of cancer drugs to tumor cells

    • Reduced side effects by sparing healthy cells

    • Combination therapies (e.g., biologics, optical, and thermal treatments)

  • Cancer Types: Effective for glioblastoma and ovarian cancer

Vision:

  • AI and Nanotechnology Convergence: Creating smarter, high-performance solutions across industries

  • Sustainability and Scalability: Focused on continuous innovation, market viability, and reducing environmental impact

How EurekaAI® Optimizes Development

  • Predictive Modeling: AI analyzes data to identify the most promising formulations

  • Cost Reduction: Streamlined research process lowers R&D costs

  • Customization: AI allows for rapid adaptation to market changes

Key Benefits of NobleFusion™ Nanoparticles

  • Size and Penetration:

    • Nanoparticles range from 1 to 100 nanometers in size

    • Can penetrate biological barriers (e.g., skin, cell membranes, blood-brain barrier)

  • Applications:

    • Medicine: Precise drug delivery, cancer treatments

    • Cosmetics: Enhanced ingredient absorption, anti-aging, and anti-inflammatory effects

    • Antimicrobials: Treats infections, combats antibiotic-resistant bacteria

    • Agriculture: Enhanced crop yields, reduced pesticide use

Future Potential

  • AI Integration: Leveraging EurekaAI® to further enhance the design and application of nanoparticles

  • Personalized Medicine: Long-term goal to expand into customized treatments based on individual needs

  • Global Impact: VerTan Technologies aims to address pressing challenges in healthcare, agriculture, and cosmetics through innovative, sustainable nanotechnology.

Vertan Technologies stands out with its IP-backed nanotechnology platform, using AI-driven formulation optimization to reduce R&D costs and accelerate commercialization. Their multi-sector application—spanning cosmetics, antimicrobials, and oncology—creates diversified revenue streams while de-risking execution.

The EurekaAI® system enhances formulation precision, increasing product efficacy and market differentiation. Additionally, their strategic partnerships, such as with MultiFrax for skincare, demonstrate a smart B2B2C go-to-market approach.

With patent protection, strong scientific leadership, and a clear commercialization roadmap, they present a compelling case for scalable, high-margin, defensible growth.